In the notice published in the New Zealand Gazette, 18 December 2003, No. 173, page 4770, the entry in lines 11 to 20 for Thalidomide Pharmion capsule is deleted and the following substituted:
Schedule
Product: Thalidomide Pharmion
Active Ingredient: Thalidomide 50mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Penn Pharmaceuticals Limited, Tredegar, Gwent, United Kingdom
Note: This consent is given subject to the following conditions:
? Only members of the Royal Australasian College of Physicians can prescribe Thalidomide.
? Douglas Pharmaceuticals Limited will manage the risk management programme relating to the distribution and use of thalidomide.
Also Note: This consent is valid for two years from the date of publication of the original notice (18 December 2003).
Dated this 5th day of May 2004.
DAVID NICHOLSON, National Services Manager, acting as Deputy Director-General, Public Health for the period
5 May 2004 to 28 May 2004 (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).